iifl-logo-icon 1

Zenlabs Ethica Ltd Share Price

42.21
(-3.63%)
Oct 21, 2024|03:44:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open41.45
  • Day's High45.8
  • 52 Wk High70
  • Prev. Close43.8
  • Day's Low41.45
  • 52 Wk Low 31.3
  • Turnover (lac)23.44
  • P/E71.8
  • Face Value10
  • Book Value15.54
  • EPS0.61
  • Mkt. Cap (Cr.)27.48
  • Div. Yield0
View All Historical Data
No Records Found

Zenlabs Ethica Ltd KEY RATIOS

Sector

Trading

Open

41.45

Prev. Close

43.8

Turnover(Lac.)

23.44

Day's High

45.8

Day's Low

41.45

52 Week's High

70

52 Week's Low

31.3

Book Value

15.54

Face Value

10

Mkt Cap (₹ Cr.)

27.48

P/E

71.8

EPS

0.61

Divi. Yield

0

Zenlabs Ethica Ltd Corporate Action

31 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

7 Sep 2024

12:00 AM

AGM

Announcement Date: 07 Sep, 2024

arrow

Zenlabs Ethica Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Zenlabs Ethica Ltd SHAREHOLDING SNAPSHOT

22 Oct, 2024|07:15 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 52.97%

Foreign: 0.00%

Indian: 52.97%

Non-Promoter- 47.02%

Institutions: 0.00%

Non-Institutions: 47.02%

Custodian: 0.00%

Share Price

Zenlabs Ethica Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

6.51

6.51

6.51

6.51

Preference Capital

0

0

0

0

Reserves

3.61

3.19

2.82

2.05

Net Worth

10.12

9.7

9.33

8.56

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

56.64

59.94

71.83

81.15

yoy growth (%)

-5.52

-16.54

-11.48

415.22

Raw materials

-46.72

-49.45

-57.11

-65.41

As % of sales

82.49

82.5

79.5

80.6

Employee costs

-3.35

-3.97

-2.8

-3.05

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0.92

-1.16

1.65

1.22

Depreciation

-0.27

-0.29

-0.2

-0.2

Tax paid

-0.09

0.43

-0.48

-0.27

Working capital

0.39

0.42

1.51

1.49

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-5.52

-16.54

-11.48

415.22

Op profit growth

-230.72

-145.92

27.25

629.77

EBIT growth

-188.2

-162.5

31.24

237.93

Net profit growth

-213.53

-162.95

22.29

459

View Ratios

No Record Found

Zenlabs Ethica Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Adani Enterprises Ltd

ADANIENT

2,936.35

118.53,38,907.86602.260.047,800.75180.55

Aegis Logistics Ltd

AEGISLOG

741.8

51.7726,037.18165.410.44732.1367.87

Cello World Ltd

CELLO

855.6

278.718,898.9216.760.17259.9565.65

Redington Ltd

REDINGTON

174.5

13.0813,641.96155.673.5510,301.5946.35

Honasa Consumer Ltd

HONASA

418.45

105.9413,592.2634.790498.434.63

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Zenlabs Ethica Ltd

Management

Register Office

Registrar Office

Managing Director & CEO

Sanjeev Kumar

Director

Him Jyoti

Independent Director

Ashok Kumar Gupta

Whole Time Director & CFO

Sanjay Dhir

Independent Director

Anurag Malhotra

Director

Kuldeep Singh

Executive Director

HITESH POPATLAL OSWAL

Company Sec. & Compli. Officer

Akshay Saxena

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993. The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network. It deals into marketing and distribution of pharmaceutical products and has grown to be of Indias top pharmaceutical companies in 2019.The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada. The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people. Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.In 2023, the Company has ventured into diversified segments like Neurology and Cytrics. It manufactures drugs for varied brands and sticks to international standards and prescribed norms. These drugs are marketed in factory packaging. As a WHO GMP certified company, the quality of each product is of highly advanced procurement & supply facility.
Read More

Company FAQs

What is the Zenlabs Ethica Ltd share price today?

The Zenlabs Ethica Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹42.21 today.

What is the Market Cap of Zenlabs Ethica Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zenlabs Ethica Ltd is ₹27.48 Cr. as of 21 Oct ‘24

What is the PE and PB ratio of Zenlabs Ethica Ltd?

The PE and PB ratios of Zenlabs Ethica Ltd is 71.8 and 2.82 as of 21 Oct ‘24

What is the 52 Week High and Low of Zenlabs Ethica Ltd?

The 52-week high/low is the highest and lowest price at which a Zenlabs Ethica Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Zenlabs Ethica Ltd is ₹31.3 and ₹70 as of 21 Oct ‘24

What is the CAGR of Zenlabs Ethica Ltd?

Zenlabs Ethica Ltd's CAGR for 5 Years at 11.95%, 3 Years at 8.28%, 1 Year at 17.25%, 6 Month at 1.74%, 3 Month at 7.87% and 1 Month at 0.43%.

What is the shareholding pattern of Zenlabs Ethica Ltd?

The shareholding pattern of Zenlabs Ethica Ltd is as follows:
Promoters - 52.98 %
Institutions - 0.00 %
Public - 47.02 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp